Nate Silver @NateSilver538
Although this is commonly asserted, there really isn't much evidence that in the medium to long run, the supply of vaccine is finite. The counterargument is that greater demand will lead to more (perhaps long-lasting) investment in the supply chain and manufacturing capabilities. — PolitiTweet.org
